The IPO Buzz: Artiva Biotherapeutics Sets Terms & Launches $130.5 Million IPO
Shortly after sunrise, Artiva Biotherapeutics, Inc. (ARTV Proposed) disclosed the terms for its revived IPO and launched the $130.5 million deal for pricing this week. Artiva Biotherapeutics is offering 8.7 million shares at a price range of $14.00 to $16.00 to raise $130.5 million, if the IPO is priced at the $15.00 mid-point. The market […]
July 15, 2024 Read More